Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C

Article Type
Changed
Display Headline
Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C
Article PDF
Author and Disclosure Information

Catherine C. Crone, MD
Inova Transplant Center, Inova Fairfax Hospital, Falls Church, VA

Geoffrey M. Gabriel, MD
121st General Hospital, Seoul, Korea

Thomas N. Wise, MD
Department of Psychiatry, Inova Fairfax Hospital, Falls Church, VA

Correspondence: Catherine C. Crone, MD, Inova Transplant Center, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042; e-mail: cathy.crone@inova.com

Dr. Crone reported that she is on the speakers’ bureau of the Pfizer corporation.

Dr. Gabriel reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Wise reported that he serves as a consultant to the Pfizer and Eli Lilly corporations and is on the speakers’ bureaus of the Pfizer, Eli Lilly, AstraZeneca, and Bristol-Myers Squibb corporations.

Publications
Page Number
S27-S32
Author and Disclosure Information

Catherine C. Crone, MD
Inova Transplant Center, Inova Fairfax Hospital, Falls Church, VA

Geoffrey M. Gabriel, MD
121st General Hospital, Seoul, Korea

Thomas N. Wise, MD
Department of Psychiatry, Inova Fairfax Hospital, Falls Church, VA

Correspondence: Catherine C. Crone, MD, Inova Transplant Center, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042; e-mail: cathy.crone@inova.com

Dr. Crone reported that she is on the speakers’ bureau of the Pfizer corporation.

Dr. Gabriel reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Wise reported that he serves as a consultant to the Pfizer and Eli Lilly corporations and is on the speakers’ bureaus of the Pfizer, Eli Lilly, AstraZeneca, and Bristol-Myers Squibb corporations.

Author and Disclosure Information

Catherine C. Crone, MD
Inova Transplant Center, Inova Fairfax Hospital, Falls Church, VA

Geoffrey M. Gabriel, MD
121st General Hospital, Seoul, Korea

Thomas N. Wise, MD
Department of Psychiatry, Inova Fairfax Hospital, Falls Church, VA

Correspondence: Catherine C. Crone, MD, Inova Transplant Center, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042; e-mail: cathy.crone@inova.com

Dr. Crone reported that she is on the speakers’ bureau of the Pfizer corporation.

Dr. Gabriel reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Wise reported that he serves as a consultant to the Pfizer and Eli Lilly corporations and is on the speakers’ bureaus of the Pfizer, Eli Lilly, AstraZeneca, and Bristol-Myers Squibb corporations.

Article PDF
Article PDF
Page Number
S27-S32
Page Number
S27-S32
Publications
Publications
Article Type
Display Headline
Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C
Display Headline
Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C
Citation Override
Cleveland Clinic Journal of Medicine 2004 May;71(suppl 3):S27-S32
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media